HKUMed develops novel combination therapy to reduce leukaemia relapse rate, extending window for bone marrow transplants
May 20, 2026
May 20, 2026
HONG KONG, May 20 -- The University of Hong Kong issued the following news release:
* * *
HKUMed develops novel combination therapy to reduce leukaemia relapse rate, extending window for bone marrow transplants
*
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel combination therapy that significantly improves treatment outcomes and s . . .
* * *
HKUMed develops novel combination therapy to reduce leukaemia relapse rate, extending window for bone marrow transplants
*
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel combination therapy that significantly improves treatment outcomes and s . . .